tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Panbela announces first patient enrolled in dose escalation study of CPP-1X-S
PremiumThe FlyPanbela announces first patient enrolled in dose escalation study of CPP-1X-S
1y ago
Is PBLA a Buy, Before Earnings?
Premium
Pre-Earnings
Is PBLA a Buy, Before Earnings?
1y ago
Panbela Therapeutics says DSMB recommends continuation of ASPIRE trial
Premium
The Fly
Panbela Therapeutics says DSMB recommends continuation of ASPIRE trial
1y ago
Panbela Therapeutics announces issuance of new patent in US, Canada
PremiumThe FlyPanbela Therapeutics announces issuance of new patent in US, Canada
1y ago
Panbela Therapeutics Updates ASPIRE Trial Timeline
Premium
Company Announcements
Panbela Therapeutics Updates ASPIRE Trial Timeline
2y ago
Panbela announces interim data analysis for ASPIRE trial pushed to Q1 of 2025
Premium
The Fly
Panbela announces interim data analysis for ASPIRE trial pushed to Q1 of 2025
2y ago
Is PBLA a Buy, Before Earnings?
PremiumPre-EarningsIs PBLA a Buy, Before Earnings?
2y ago
Panbela Therapeutics Regains Compliance with Nasdaq Standards
Premium
Company Announcements
Panbela Therapeutics Regains Compliance with Nasdaq Standards
2y ago
Panbela Therapeutics regains compliance with Nasdaq listing standards
Premium
The Fly
Panbela Therapeutics regains compliance with Nasdaq listing standards
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100